Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Monica M. Bowen
Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 DOI:
Diabetes Spectrum
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Optimal Prandial Timing of Bolus Insulin in Diabetes Management: A Review
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
BeAM Value: An Indicator of the Need to Initiate and Intensify Prandial Therapy in Patients With Type 2 Diabetes Mellitus Receiving Basal Insulin
BMJ Open Diabetes Research and Care
Endocrinology
Metabolism
Diabetes
Impact of Metformin Versus the Prandial Insulin Secretagogue, Repaglinide, on Fasting and Postprandial Glucose and Lipid Responses in Non-Obese Patients With Type 2 Diabetes
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Metformin Reduces Post-Prandial Insulin Needs in Type I (Insulin-Dependent) Diabetic Patients: Assessment by the Artificial Pancreas
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pdb74 - Ideglira Versus Iglarlixi for Patients With Inadequately Controlled Type 2 Diabetes on Basal Insulin: A Long-Term Cost-Effectiveness Analysis in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental